Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nazara Technologies Limited Regulatory Filings 2026

May 12, 2026

61292_rns_2026-05-12_b5f68c2d-b7aa-4b8f-b1e0-1f260434cda6.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Nazara

May 12, 2026

To,

Listing Compliance Department
BSE Limited
Phiroze Jeejeebhoy Towers
Dalal Street,
Mumbai - 400 001.
Scrip Code: 543280

Listing Compliance Department
National Stock Exchange of India Limited
Exchange Plaza, Plot No. C/1. G Block,
Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051.
Scrip Symbol: NAZARA

Dear Sir/Madam,

Subject: Monitoring Agency Report for the quarter ended on March 31, 2026

With reference to the above subject, pursuant to Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, read with Regulation 162A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”), we are enclosing the Monitoring Agency Report of the Company for the quarter ended March 31, 2026, issued by ICRA Limited, the Monitoring Agency, appointed by the Company to monitor the utilisation of proceeds raised through the issuance and allotment of 50,00,000 fully paid up equity shares of the Company having face value of Rs. 4/- each at a price of Rs. 990/- (including a premium of Rs. 986/-) per equity share, by way of Preferential Issue under Chapter V of SEBI ICDR Regulations.

You are requested to take the same on record.

Thanking you.

Yours faithfully,

For Nazara Technologies Limited

ARUN SHIVA
BHANDARI
Digitally signed by ARUN SHIVA BHANDARI
Date: 2026.05.12
19:15:25 +05'30'

Arun Bhandari
Company Secretary and Compliance Officer
Encl. As above

Nazara Technologies Limited
CIN: L72900MH1999PLC122970
11th Floor, Avighna House, Dr. A.B. Road,
Worli, Mumbai - 400018.
91-22-40330800 / 22810303 / 22813030
[email protected]
www.nazara.com


ICRA

ICRA Limited

Date: May 12, 2026

Mr. Rakesh Shah
Chief Financial Officer
Nazara Technologies Limited
11th Floor Avighna House,
Dr Annie Besant Road,
Worli Naka Mumbai – 400018

Dear Sir,

Re: Final Monitoring Agency report of Nazara Technologies Limited for Q4 FY2026

Please refer to agreement dated January 29, 2025, appointing ICRA Limited as the Monitoring Agency (MA) for Nazara Technologies Limited’s Preferential Issue.

After due consideration, ICRA has prepared the attached final Monitoring Agency report as per SEBI (Issue of Capital and Disclosure Requirements) Regulations for Q4 FY2026.

Please note that the Monitoring Agency report does not constitute a commentary on the quality of the objects of the issue, appropriateness or reasonableness of costs or spending by Nazara Technologies Limited against any objects / heads or assurance on outcome of such spending.

We thank you for your kind cooperation extended during the course of Q4 FY2026. Should you require any clarification, please do not hesitate to get in touch with us.

We look forward to your communication and assure you of our best services.

With kind regards

For ICRA Limited

Parul Goyal
Narang
Digitally signed
by Parul Goyal
Narang
Date: 2026.05.12
17:57:46 +05'30'

Parul Goyal Narang
Vice President & Head- Process Excellence
[email protected]

Building No. 8, 2nd Floor, Tower A
DLF Cyber City, Phase II
Gurugram – 122002, Haryana
Tel.: +91.124.4545300
CIN: L749999DL1991PLC042749
Website: www.icra.in
Email: [email protected]
Helpdesk: +91 9354738909
Registered Office: B-710, Statesman House, 148, Barakhamba Road, New Delhi 110001. Tel.: +91.11.23357940-41

RATING • RESEARCH • INFORMATION

Sensitivity Label : Confidential


ICRA
March 2026

MONITORING AGENCY REPORT FORMAT

Name of the Issuer: Nazara Technologies Limited

For the Quarter ended: March 31, 2026.

Name of the Monitoring Agency (MA): ICRA Limited

(a) Deviation from the objects of the issue:
No deviation - the utilization of the issuance proceeds is in line with the objects of the issue.

(b) Range of deviation:
No deviation

Declaration:

We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain creditrelated analyses. We confirm that we do not perceive any conflict of interest in such relationship/ interest while monitoring and reporting the utilization of the issue proceeds by the issuer. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.

Signature:

Parul
Goyal
Narang

Digitally signed
by Parul Goyal
Narang
Date: 2026.05.12
18:04:49 +05'30'

Parul Goyal Narang
Vice President & Head- Process Excellence

Analyst: Subhechha Banerjee
Quality Analyst: Parul Narang

Sensitivity Label : Confidential


ICRA
March 2026

1. Issuer Details

Name of the Issuer: Nazara Technologies Limited

Name(s) of the promoter:

Promoters
Nitish Mittersain
Vikash Mittersain
Mitter Infotech LLP
Plutus Wealth Management LLP
Axana Estates LLP

Source: BSE

Industry/ sector to which it belongs:
- Software.

2. Issue Details

Issue Period: Opening Date: NA
Closing Date: NA

Type of Issue: Preferential Issue

Type of specified securities: Preferential issue of Equity Shares

IPO Grading, if any: Not Applicable

Issue Size (Rs. Crore): Issue Size: INR 495.00 crores (50,00,000 fully paid-up Equity Shares of INR 990.00 each including premium of INR 986.00 each)

With OFS portion: Not Applicable.
Excluding OFS portion: Not Applicable
Gross Proceeds: INR 495.00 Crore.

Note: Issue related expenses incurred till Q4FY26 are INR 0.38 Crore. ICRA will be monitoring the Proceeds of INR 495.00 Crore.

Sensitivity Label : Confidential


ICRA
March 2026

  1. Details of the arrangement made to ensure the monitoring of issue proceeds
Particulars Reply Source of information, certifications considered by the Monitoring Agency for the preparation of report Comments of the Monitoring Agency Comments of the Issuer's Board of Directors
Whether all utilization is as per the disclosures in the Offer Document? Yes -Peer reviewed CA Certificate
-Confirmation from management
-Bank Statement
-Offer Letter
-Notice of EOGM held on February 13, 2025 No deviation observed
Whether shareholder approval has been obtained in case of material deviations^{e} from expenditures disclosed in the Offer Document? Not Applicable As confirmed by the Issuer's management No comments
Whether the means of finance for the disclosed objects of the issue has changed? No As confirmed by the Issuer's management No comments
Is there any major deviation observed over the earlier monitoring agency reports? No No deviation observed No comments
Whether all Government/statutory approvals related to the object(s) have been obtained? Not Applicable As confirmed by the Issuer's management No comments
Whether all arrangements pertaining to technical assistance/ collaboration are in operation? Not Applicable As confirmed by the Issuer's management No comments
Are there any favorable events improving the viability of these object(s)? No As confirmed by the Issuer's management As understood from the Issuer's management
Are there any unfavorable events affecting the viability of the object(s)? No As confirmed by the Issuer's management As understood from the Issuer's management
Is there any other relevant information that may materially affect the decision making of the investors? No As confirmed by the Issuer's management As understood from the Issuer's management

8 Where material deviation is defined to mean:
(a) Deviation in the objects or purposes for which the funds had been raised
(b) Deviation in the amount of funds actually utilized by more than 10% of the amount specified in the offer document

Sensitivity Label : Confidential


ICRA
March 2026

4. Details of the object(s) to be monitored

(i) Cost of object(s)

S. N. Item Head Source of information, certifications considered by the Monitoring Agency for the preparation of report Original cost (as per the offer document) [Rs. Crore] Revised cost [Rs. Crore] Comments of the Monitoring Agency Comments of the Issuer's Board of Directors
Reason for cost revision Proposed financing option Particulars of firm arrangements made
1 Expansion and growth - Notice of EOGM held on February 13, 2025 Upto 371.25 - No comments
2 General Corporate Purposes & Preferential Issue expenses - Notice of EOGM held on February 13, 2025 -Issuer Confirmation Upto 123.75 - No comments
Total 495.00 -

Sensitivity Label : Confidential


ICRA

March 2026

(ii) Progress in the object(s)

S.N. Item Head Source of information, certifications considered by the Monitoring Agency for the preparation of report Amount as proposed in the offer document [Rs. Crore] Amount utilized [Rs. Crore] Total unutilized amount [Rs. Crore] Comments of the Monitoring Agency Comments of the Issuer's Board of Directors
As at the beginning of the quarter During the quarter At the end of the quarter Reasons for idle funds Proposed course of action
1 Expansion and growth - Notice of EOGM held on February 13, 2025
- Peer reviewed CA Certificate
- Bank Statement Upto 371.25 27.94 36.64 64.58 306.67 The issuer has utilized the proceeds of INR 0.55 Crore as reimbursement for the expenditure, which was funded earlier through Internal Accruals
2 General Corporate Purposes & Preferential Issue expenses - Notice of EOGM held on February 13, 2025
- Peer reviewed CA Certificate
- Bank Statement Upto 123.75 0.38 - 0.38 123.37 Includes issue expenses of INR 0.38 crore
Total 495.00 28.32 36.64 64.96 430.04

Sensitivity Label : Confidential


ICRA
March 2026

(iii) Deployment of unutilized proceeds

S.N. Type of instrument and name of the entity invested in Amount invested [Rs. Crore] Maturity date Earning [Rs. Crore] Return on Investment [%] Market Value as at the end of quarter [Rs. Crore]
1 Mutual Fund with Aditya Birla Sun Life Arbitrage Fund Growth 30.00 NA 1.51 5.03% 31.51
2 Mutual Fund with Kotak Arbitrage Fund Direct Growth 30.00 NA 1.43 4.77% 31.43
3 Mutual Fund with Bandhan Money Manager Fund 0.71 NA 0.03 4.23% 0.74
4 Mutual Fund with Kotak Low Duration Fund 32.48 NA 1.61 4.96% 34.09
5 Mutual Fund with Bandhan Income Plus Arbitrage Active FoF 39.81 NA 1.43 3.59% 41.24
6 Mutual Fund with ICICI Prudential Income Plus Arbitrage Active FoF 40.00 NA 1.70 4.25% 41.70
7 Mutual Fund with ICICI Prudential Banking & PSU Debt Direct Growth 40.00 NA 1.64 4.10% 41.64
8 Mutual Fund with Invesco India Arbitrage Fund Direct Growth 30.00 NA 1.54 5.13% 31.54
9 Mutual Fund with TRUSTMF Corporate Bond Fund – Direct Plan Growth 20.00 NA 0.63 3.15% 20.63
10 Mutual Fund with Tata Arbitrage Fund Direct Growth 30.00 NA 1.46 4.87% 31.46
11 Mutual Fund with Tata Gilt Securities Fund Direct Growth 40.00 NA -0.82 -2.05% 39.18
12 Mutual Fund with SBI Short Term Debt Fund Direct Growth 25.00 NA 1.00 4.00% 26.00
13 Mutual Fund with SBI Income Plus Arbitrage Active FoF Direct Growth 25.00 NA 0.87 3.48% 25.87
14 Fixed Deposit with IndusInd Bank 45.00 28-Sep-26 2.49 5.53% 47.49
16 Balance in Standard Chartered Bank 2.04 - - - 2.04
Total 430.04 16.52 446.56

Source: As certified by Nikunj Raichura & Associates

Sensitivity Label : Confidential


ICRA
March 2026

(iv) Delay in the implementation of the object(s)

S.N. Completion date Comments of the Issuer's Board of Directors
Object(s) As per the offer document Actual Delay [Number of days or months] Reason for delay Proposed course of action
1 Expansion and growth Within 36 months from the date of receipt of funds. On Schedule NA
2 General Corporate Purposes & Preferential Issue expenses Within 36 months from the date of receipt of funds. On Schedule NA

Source: Notice of EOGM held on February 13, 2025

  1. Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document
S.N. Item Head Amount [Rs. Crore] Source of information, certifications considered by the Monitoring Agency for the preparation of report Comments of the Monitoring Agency Comments of the Issuer's Board of Directors
1 Issue expenses 0.38 - Bank statements
- Peer reviewed CA Certificate No Comment
Total 0.38

Sensitivity Label : Confidential